TEVA PHARMA (Israel) Today

TEVA PHARMA is trading at 2991.00 as of the 20th of September 2021, a 0.71 percent up since the beginning of the trading day. The stock's open price was 2970.0. Equity ratings for TEVA PHARMA IND are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of May 2020 and ending today, the 20th of September 2021. Click here to learn more.
Valuation Profit Patterns
Check how we calculate scores

TEVA PHARMA Stock Profile

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Petach Tikva, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel. more on TEVA PHARMA
TEVA PHARMA IND is not yet fully synchronised with the market data
TEVA PHARMA IND generates negative expected return over the last 90 days
TEVA PHARMA IND is unlikely to experience financial distress in the next 2 years
The company reported the revenue of 16.28 B. Net Loss for the year was (3.98 B) with profit before overhead, payroll, taxes, and interest of 7.73 B.
Legal NameTEVA PHARMA IND
CEOCarlo Notaristefani  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of TEVA PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
TEVA PHARMA IND (TEVA) is traded on Tel Aviv Stock Exchange in Israel and employs 37,100 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 3300 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TEVA PHARMA's market, we take the total number of its shares issued and multiply it by TEVA PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. TEVA PHARMA IND operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 1.1 B outstanding shares. TEVA PHARMA IND has accumulated about 1.74 B in cash with 506 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58.
Check TEVA PHARMA Probability Of Bankruptcy

TEVA PHARMA Stock Price Odds Analysis

What are TEVA PHARMA's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of TEVA PHARMA jumping above the current price in 90 days from now is about 89.92%. The TEVA PHARMA IND probability density function shows the probability of TEVA PHARMA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon TEVA PHARMA IND has a beta of -0.3406. This usually implies as returns on benchmark increase, returns on holding TEVA PHARMA are expected to decrease at a much lower rate. During the bear market, however, TEVA PHARMA IND is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. TEVA PHARMA IND is significantly underperforming DOW.
 Odds Down 2991.0HorizonTargetOdds Up 2991.0 
9.99%90 days
 2,991 
89.92%
Based on a normal probability distribution, the odds of TEVA PHARMA to move above the current price in 90 days from now is about 89.92 (This TEVA PHARMA IND probability density function shows the probability of TEVA PHARMA Stock to fall within a particular range of prices over 90 days) .

TEVA PHARMA Historical Income Statement

TEVA PHARMA IND Income Statement is one of the three primary financial statements used for reporting TEVA PHARMA's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of TEVA PHARMA IND revenue and expense. TEVA PHARMA Income Statement primarily focuses on the company's revenues and expenses during a particular period.
The current year Revenues is expected to grow to about 19.9 B, whereas Direct Expenses is forecasted to decline to about 8.6 B. View More Fundamentals

TEVA PHARMA Stock Against Markets

Picking the right benchmark for TEVA PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in TEVA PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for TEVA PHARMA is critical whether you are bullish or bearish towards TEVA PHARMA IND at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TEVA PHARMA stock to make a market-neutral strategy. Peer analysis of TEVA PHARMA could also be used in its relative valuation, which is a method of valuing TEVA PHARMA by comparing valuation metrics with similar companies.

TEVA PHARMA Corporate Directors

TEVA PHARMA corporate directors refer to members of a TEVA PHARMA board of directors. The board of directors generally takes responsibility for the TEVA PHARMA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of TEVA PHARMA's board members must vote for the resolution. The TEVA PHARMA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Moshe Many - Independent DirectorProfile
Richard Lerner - Independent DirectorProfile
Galia Maor - Independent DirectorProfile
JeanMichel Halfon - Statutory - independent directorProfile
Additionally, take a look at World Market Map. Note that the TEVA PHARMA IND information on this page should be used as a complementary analysis to other TEVA PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Other Tools for TEVA PHARMA Stock

When running TEVA PHARMA IND price analysis, check to measure TEVA PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TEVA PHARMA is operating at the current time. Most of TEVA PHARMA's value examination focuses on studying past and present price action to predict the probability of TEVA PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move TEVA PHARMA's price. Additionally, you may evaluate how the addition of TEVA PHARMA to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go